Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy in transgender men can cause acne.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Medical care for transgender youth should be individualized and supportive.

Finasteride effectively treats hair loss in transgender men with few side effects.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Feminizing hormone therapy increases kidney filtration rate.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

The document summarized various dermatology studies and case reports.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

The LGBT-focused curriculum improved dermatology residents' confidence in treating LGBT patients.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.